- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- N-(4-methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-am
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
N-(4-methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine
| EU orphan designation number: | EU/3/16/1618
|
| Active ingredient: | N-(4-methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine |
| Indication: | Treatment of glioma |
| Sponsor: | FLAG Therapeutics Ltd
Cheapside House, 138 Cheapside, London EC2V 6BJ, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 24/02/2016 | Orphan designation | EMA/OD/206/15 | (2016)1111 of 17/02/2016 |
CONTACT
EU links
Directorate General Health & Consumers